Efficacy of Antioxidant Supplementation in Improving Endocrine, Hormonal, Inflammatory, and Metabolic Statuses of PCOS: A Meta-analysis and Systematic Review
Junhui He,Xiao-Can Lei,Renhe Deng,Yanhong Wei,Shun Zhang,Mingxuan Su,Masong Tang,Jinyuan Wang,weihua nong
DOI: https://doi.org/10.1039/d3fo02824k
IF: 6.3173
2024-01-19
Food & Function
Abstract:We performed this systematic review and meta-analysis to evaluate the association between antioxidant supplementation and PCOS patients. The following databases were searched through March 2023: PubMed, Embase, The Cochrane Library, and Web of Science. This study included a total of 49 articles and 62 studies, and the sample consisted of 1657 PCOS patients from the antioxidant group and 1619 PCOS patients from the placebo group. The meta-analysis revealed that fasting blood glucose (FBG) levels (standardized squared variance (SMD)): -0.31 [95% CI: -0.39,- 0.22], p < 0.00001), the steady-state model assessment of insulin resistance(HOMA-IR) (SMD: -0.68 [95%, -0.87, -0.50], p < 0.00001) and insulin levels (SMD): -0.68 [95%, -0.79, -0.58], p <0.00001) in PCOS patients taking antioxidants were significantly lower than those in the placebo group. Compared with the placebo group, total cholesterol (TC) levels (SMD: -0.38[95%:-0.56,-0.20], p<0.001), low-density lipoprotein (LDL-C) levels (SMD: -0.24 [95%:-0.37, -0.10], p = 0.0008) and very low-density lipoprotein (VLDL) levels (SMD: -0.53 [95%:-0.65, -0.41], p < 0.00001) is lower in PCOS patients taking antioxidant supplements. Total testosterone (TT)(SMD:-0.78[95%:-1.15,-0.42],p<0.0001),dehydroepiandrosterone(DHEAS)(SMD:-0.42[95%:-0.58,-0.25],p<0.00001), and MF-G SCORES (SMD:-0.63[95%:-0.98,-0.28], p=0.0004) in patients taking antioxidant supplements is lower residually. C-reactive protein (CRP) levels (SMD:-0.48[95%: -0.63, -0.34], p < 0.000001), BMI (MD: -0.27[95%, -0.50, -0.03], p = 0.03), weight (MD: -0.73[95%, -1.35, -0.11, p = 0.02), diastolic blood pressure (MD: -3.78 [95%: -6.30,-1.26], p =0.003) is significantly lower. In addition, compared with the placebo group, The sex hormone binding protein (SHBG) level (SMD:0.23[95%:0.07,0.38], p=0.004), high-density lipoprotein (HDL-C)level (SMD:0.11[95%:0.01,0.20], p=0.03), total antioxidant capacity (TAC) level (SMD:0.59[95%:0.31,0.87], p<0.0001) and quantitative insulin sensitivity index (QUICKI) level (MD:0.01[95%:0.01,0.02], p <0.00001) were higher of PCOS patients who took antioxidant supplements. Antioxidant supplements did not affect other analyzed parameters in PCOS patients, including follicle-stimulating hormone (FSH), free androgen index (FAI), NO, glutathione (GSH), malondialdehyde (MDA), and diastolic blood pressure (DBP). Our study may provide a new treatment strategy for clinical PCOS patients, and more high-quality trials are expected to be carried out, especially for PCOS patients in Western countries, where lacks trials of antioxidant intervention in PCOS patients.
biochemistry & molecular biology,food science & technology